BC

Boxer Capital Portfolio holdings

AUM $2.04B
This Quarter Return
-16.91%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
–
AUM
$1.45B
AUM Growth
+$1.45B
Cap. Flow
+$125M
Cap. Flow %
8.6%
Top 10 Hldgs %
54.05%
Holding
69
New
18
Increased
8
Reduced
4
Closed
7

Top Buys

1
RVMD icon
Revolution Medicines
RVMD
$66.8M
2
REGN icon
Regeneron Pharmaceuticals
REGN
$65.9M
3
BDTX icon
Black Diamond Therapeutics
BDTX
$50.3M
4
SAGE
Sage Therapeutics
SAGE
$34M
5
PASG icon
Passage Bio
PASG
$29.7M

Top Sells

1
MDCO
Medicines Co
MDCO
$82.1M
2
VXX icon
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$42.8M
3
SRPT icon
Sarepta Therapeutics
SRPT
$29M
4
APLS icon
Apellis Pharmaceuticals
APLS
$24.5M
5
LABD icon
Direxion Daily S&P Biotech Bear 3X Shares
LABD
$23M

Sector Composition

1 Healthcare 88.63%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
MRTX
1
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$136M 9.25% 1,765,560 +50,000 +3% +$3.84M
IMMU
2
DELISTED
Immunomedics Inc
IMMU
$114M 7.76% 8,450,000 – –
ONC
3
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
$114M 7.76% 925,000 – –
ODT
4
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$92.9M 6.33% 3,363,377 – –
RVMD icon
5
Revolution Medicines
RVMD
$7.1B
$66.8M 4.55% +3,049,764 New +$66.8M
REGN icon
6
Regeneron Pharmaceuticals
REGN
$61.5B
$65.9M 4.49% +135,000 New +$65.9M
SWTX
7
DELISTED
SpringWorks Therapeutics
SWTX
$56M 3.82% 2,075,905 – –
BDTX icon
8
Black Diamond Therapeutics
BDTX
$157M
$50.3M 3.43% +2,014,858 New +$50.3M
SGEN
9
DELISTED
Seagen Inc. Common Stock
SGEN
$46.2M 3.15% 400,000 -100,000 -20% -$11.5M
SAGE
10
DELISTED
Sage Therapeutics
SAGE
$44M 3% 1,532,510 +1,182,510 +338% +$34M
RCUS icon
11
Arcus Biosciences
RCUS
$1.13B
$42.8M 2.92% 3,084,883 +1,412,650 +84% +$19.6M
QURE icon
12
uniQure
QURE
$896M
$36.3M 2.48% 765,400 – –
ESPR icon
13
Esperion Therapeutics
ESPR
$448M
$30.7M 2.1% 975,000 – –
ALLK
14
DELISTED
Allakos
ALLK
$30M 2.05% 675,000 – –
PASG icon
15
Passage Bio
PASG
$22.7M
$29.7M 2.02% +1,883,315 New +$29.7M
BCEL
16
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$28.7M 1.96% 1,733,583 – –
DBVT
17
DBV Technologies
DBVT
$264M
$27.6M 1.88% 7,034,598 +650,000 +10% +$2.55M
ARGX icon
18
argenx
ARGX
$43.6B
$26.3M 1.8% 200,000 – –
KDMN
19
DELISTED
Kadmon Holdings, Inc.
KDMN
$26M 1.77% 6,205,882 – –
GOSS icon
20
Gossamer Bio
GOSS
$562M
$22.2M 1.51% 2,185,000 – –
FOLD icon
21
Amicus Therapeutics
FOLD
$2.34B
$21.5M 1.46% 2,325,000 – –
BMRN icon
22
BioMarin Pharmaceuticals
BMRN
$11.2B
$21.1M 1.44% 250,000 – –
RCKT icon
23
Rocket Pharmaceuticals
RCKT
$354M
$20.5M 1.39% 1,466,051 – –
ANAB icon
24
AnaptysBio
ANAB
$569M
$18.4M 1.25% 1,300,000 – –
BLU
25
DELISTED
BELLUS Health Inc.
BLU
$17.7M 1.21% 1,775,000 – –
1
2 3